Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Rectal Neoplasms × Chemoradiotherapy, Adjuvant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Esophageal Neoplasms 2 Resectable Pancreatic Cancer 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

Oxaliplatin 178 Capecitabine 171 Fluorouracil 154 Leucovorin 107 Radiotherapy 105 Irinotecan 93 Bevacizumab 68 Surgical Procedures, Operative 48 Drug Therapy 38 Cetuximab 38 Radiation 34 Neoadjuvant Therapy 33 Chemoradiotherapy 29 Folfox protocol 28 XELOX 22 Chemotherapy, Adjuvant 21 Magnetic Resonance Spectroscopy 20 Radiotherapy, Intensity-Modulated 19 Surveys and Questionnaires 17 Proctectomy 16 Biopsy 16 Early Intervention, Educational 14 trifluridine tipiracil drug combination 12 Panitumumab 12 Floxuridine 12 regorafenib 11 Nivolumab 11 Laparoscopy 11 Celecoxib 11 tislelizumab 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02371304 2020-05-21

TESAR

Amsterdam UMC, location VUmc

Phase 3 Unknown

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡